Abstract submission for ARCC2021 is Now Closed. Please email Rebecca.Mercer@ontariohealth.ca to inquire about the potential to include your late-breaking work as part of ARCC2021.
Submitters will be notified by the end of March 2021 regarding presentation status.
View the 2021 ARCC Abstract Guidelines here
Questions? Contact us at email@example.com
Historically, ARCC has offered travel support for students and/or new professionals attending at our conference. With the switch to a virtual format, we will not be offering travel awards this year, but want to let you know we are working on developing a program to offer additional awards and supports at ARCC2021.
To be eligible for an award, the student or new professional must be submitting an abstract to and presenting at the ARCC2021. We will provide additional details in the coming months – and invite any suggestions you may have for how we can support trainees at ARCC2021. Email us at ARCC@cc-arcc.ca or contact Rebecca at Rebecca.Mercer@ontariohealth.ca
Registration for ARCC2021 is closed.
With the support of our Founding Partner and Funder, the Canadian Cancer Society, we are not collecting registration fees for the 2021 ARCC Conference. Instead, we ask that you “Donate what you can” to the Canadian Cancer Society to support research initiatives across Canada. Recommended donation amounts are provided based on 50% of the “Early Bird” rates charged at previous ARCC conferences.
Click the below links to donate to the Canadian Cancer Society:
Students & New Professionals* – $25
Patient or Caregiver – $25
Regular ARCC Members – $50
Non-Members – $100
Industry – $250
*Note a New Professional is defined as someone who received their final degree within the last 5 years
Contact Rebecca.Mercer@ontariohealth.ca if you have any questions.
The Canadian Centre for Applied Research in Cancer Control (ARCC) is pleased to announce that its 10th annual conference, ARCC2021, will take place virtually on May 17th and 18th 2021. The objective of this conference is to bridge a connection between researchers and decision-makers, using health economics, services, policy and ethics research to improve cancer control and the delivery of cancer care.
Stay tuned for information about invited speakers!
Dr. Adalsteinn Brown, D. Phil
Adalsteinn (Steini) Brown is the Dean of the Dalla Lana School of Public Health at the University of Toronto. Prior to becoming Dean, Steini was the Director of the Institute of Health Policy, Management and Evaluation and the Dalla Lana Chair of Public Health Policy also at the University. Other past roles include senior leadership roles in policy and strategy within the Ontario Government, founding roles in start-up companies, and extensive work on performance measurement. He received his undergraduate degree in government from Harvard University and his doctorate from the University of Oxford, where he was a Rhodes Scholar.
Prof. Karen Canfell, D. Phil
Professor Karen Canfell is the inaugural Director of the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. She is an epidemiologist, modeller, and a translationally-focused population health researcher. She has led evaluations of new cancer screening approaches for government agencies in several countries. She currently leads Compass, which is the first major international experience of cervical screening in an HPV-vaccinated population. Her team’s work underpins the 2017 transition of the National Cervical Screening Program in Australia from Pap smears to 5-yearly HPV-based screening. She currently has active collaborative modelling grants from the US NIH and WHO to model cervical cancer prevention in the USA and globally. Her work as one of the co-leads of the WHO Cervical Cancer Elimination Modelling Consortium was presented and discussed at the Executive Board of the World Health Assembly in 2020 and supported the formal resolution by WHO to support the cervical cancer elimination initiative, launched in late 2020.
Mr. Conrad Eder, BA
Conrad Eder is the Policy Analyst at the Canadian Cancer Survivor Network, a national network of patients, families, survivors, friends, and community partners. Their goal is to educate the public and policy makers about gaps in cancer care, and encourage policy development to alleviate the physical, psychological, and financial impacts of cancer.
Conrad is passionate about analyzing and understanding the impact of health policies on Canadians. His current research focuses on understanding the extent to which cancer patients, and their families, have been physically and psychologically impacted by delays accessing cancer care, as a result of COVID-19.
In 2020 Conrad received his B.A. in Economics from Laurentian University, that same year he was recognized by the Fraser Institute as a Canadian Young Leader for demonstrating a keen ability to contribute to the national policy discussion.
An avid sports fan and classical music lover, Conrad’s hobbies include playing chess and spending time at his cottage.
Dr. Malcolm King, PhD
Professor Malcolm King, PhD, FCAHS, is a member of the Mississaugas of the Credit First Nation (Ontario, Canada) and a health researcher at the University of Saskatchewan (Saskatchewan, Canada), having joined the Department of Community Health & Epidemiology in October 2017. He serves as the Scientific Director of SCPOR, the Saskatchewan Centre for Patient-Oriented Research, and he continues to teach and do research in Indigenous health and wellness, with a particular focus on engagement. Dr. King served as the Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Aboriginal Peoples’ Health from 2009 to 2016, where he spearheaded the development of a national health research agenda aimed at improving wellness and achieving health equity for First Nation, Métis, and Inuit people in Canada.
Dr. Robin McGee, PhD
Dr. Robin McGee is a registered clinical psychologist who has worked in health and education for over 30 years. Her award-winning book The Cancer Olympics describes her fight for medical justice and fair chemotherapy policy after serious medical negligence. For her advocacy work in cancer care and patient safety, she was decorated with the Sovereign’s Medal for Volunteers by the Governor-General of Canada. Also, she has been awarded the Canadian Cancer Society’s highest honour, the National Medal of Courage. Proceeds of her book go to cancer support programs. She can be found on the web (www.thecancerolympics.com), Facebook, and on Twitter (@TCOrobin). Robin is currently in treatment for a recurrence of her colorectal cancer. Her blog illustrates her cancer experience using famous rock songs.
Dr. Danielle Rodin, MD, MPH
Danielle Rodin, MD, MPH, FRCPC, is a radiation oncologist at Princess Margaret Cancer Centre (PM) and an Assistant Professor in the Department of Radiation Oncology at the University of Toronto (UTDRO). She is Director of the Global Cancer Program at PM, Director of Equity, Diversity, and Professionalism at UTDRO, and is an elected member of the Board of Directors for the Union for International Cancer Control in Geneva. Her clinical interests are in breast cancer and hematologic malignancies and she is a health services researcher, with interests in health technology assessment, global health systems, and large database analyses of cost and quality in cancer care. Dr. Rodin received her B.A. (Hons.) from McGill University, her medical degree from the University of Toronto, and her Master of Public Health from Harvard University. She was the 2017-2018 Harkness Fellow in Health Care Policy and Practice in the Department of Health Policy and Management at the Harvard T. H. Chan School of Public Health, where she focused on low-value care across international health systems.
Hon. Stephen Samis, MA
Stephen Samis was appointed Deputy Minister, Health and Social Services, Government of Yukon in August 2017. He has over 25 years experience in health and health care, advancing evidence-informed health policy and population health to improve health systems and the health of Canadians.
Prior to his appointment as Deputy Minister, he spent seven years at the Canadian Foundation for Healthcare Improvement (CFHI) in Ottawa as Vice-President, Programs. At CFHI, he played a leadership role in transforming the organization, designing and implementing new programs, developing new partnerships, and securing on-going funding for the Foundation from the federal government.
Stephen’s previous roles included National Director, Health Policy, Heart and Stroke Foundation of Canada and Manager, Research, Analysis and Infrastructure for the Canadian Population Health Initiative, CIHI.
Stephen began his career in British Columbia, where he worked on strategic policy initiatives at the Worker’s Compensation Board and led, among other initiatives, the development of BC’s Framework for Action on HIV/AIDS (1998) within the BC Ministry of Health.
Stephen holds a Master’s degree in Sociology from Simon Fraser University in British Columbia, and is currently a member of the Advisory Council of the Canadian Population Health Initiative, part of the Canadian Institute for Health Information (CIHI), as well as the Board of Directors of the Canadian Agency for Drugs and Technologies in Health (CADTH). Over his career Stephen has been a frequent spokesperson on a variety of health issues on television, radio and in print media.
Dr. Jon Tonita, PhD
Dr. Jon Tonita, MSc, PhD, is the President and Chief Executive Officer (CEO) of the Saskatchewan Cancer Agency. Dr. Tonita has been with the Cancer Agency since 1996. He was the Vice President of the Population Health, Quality and Research Division for over a decade prior to accepting the role of CEO in 2017. In September 2020, he also became the chair of the Canadian Association of Provincial Cancer Agencies (CAPCA).
Dr. Tonita received his PhD from Community Health and Epidemiology, College of Medicine, University of Saskatchewan in 2009. He has been very involved in the development and implementation of prevention and early detection programs. As well, he has collaborated on numerous research projects related to clinical outcomes.
Jon has lived in Saskatchewan for 37 years raising three children. His favourite pastimes include travel and fitness. He has a love for northern Saskatchewan and Prince Albert National Park where he often goes hiking and kayaking in the fall or snow shoeing in winter.
Dr. Kelvin Chan, MD, FRCP, MSc, PhD - (ARCC Co-Director)
Dr Kelvin Chan is a Medical Oncologist at the Sunnybrook Odette Cancer Centre, an Associate Professor at the University of Toronto, and an associate scientist at the Sunnybrook Research Institute. He specializes in GI oncology and Head and Neck oncology. He has recently completed his PhD in Biostatistics (focusing on statistical methods in health economic evaluations) at the Dalla Lana School of Public Health, University of Toronto.
As a clinical epidemiologist and biostatistician, Dr. Chan’s research interests include health services research, health technology assessment, meta-analysis including network meta-analysis, cost-effectiveness analyses, and statistical methods research in health economics. He is the Co-Director at the Canadian Centre for Applied Research in Cancer Control (ARCC), funded by the Canadian Cancer Society (CCS).
Professionally, Dr Chan has an interest in cancer drug reimbursement related issues. He is a member of multiple provincial and national committees related to cancer drug assessments and recommendations including membership at the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC), the Committee to Evaluate Drug (CED) and the Interim Chair for the Ontario Steering Committee of Cancer Drugs (OSCCD), Ontario MOHLTC and Cancer Care Ontario. He is also the Clinical Lead for the Provincial Drug Reimbursement Programs (PDRP) at Cancer Care Ontario (CCO).
Dr. Manraj Kaur, PT, PhD (Student/New Professional Representative)
Manraj Kaur is a Canadian Institutes of Health Research’s postdoctoral fellow at the Patient-Reported Outcomes, Value and Experience (PROVE) Center, Brigham and Women’s Hospital and is cross-appointed at Harvard Medical School, Boston, United States. Her value-based healthcare-relevant research focuses on breast cancer programs using methods of decision science and economic evaluation, including preference assessment. For her doctoral thesis, Manraj completed the development of a preference-based instrument for assessing healthcare interventions in women diagnosed with breast cancer (BREAST-Q Utility module). During her postdoctoral fellowship, she will assess the psychometric properties of the Utility module and develop preference weights. Dr Kaur is also interested in understanding and measuring the impact of cancer diagnosis and treatment interventions on the health-related quality of life using patient-reported outcome instruments using modern psychometric methods.
Ms. Valerie McDonald, MSW (Patient & Family Representative)
Valerie McDonald earned her MSW from the University of Toronto and currently works as a free-lance writer, editor and qualitative researcher. Valerie’s interest in cancer is deeply personal. Within a five year period, her eldest daughter was treated for Burkitt’s Lymphoma, her mother died of lung cancer, and her second daughter died after relapsing on treatment for Acute Lymphoblastic Leukemia. She has volunteered in many capacities in the health care sector since 1996 to promote family and patient partnerships and to advocate for more effective palliative care. As a writer and researcher, Ms. McDonald worked on initiatives led by the Centre for Effective Practice for the Ontario Ministry of Health, CAMH, and Cancer Care Ontario. She has developed family resources for the Canadian Cancer Society and Canadian Virtual Hospice.
Dr. Rebecca Mercer, PhD (ARCC Network Manager)
Rebecca Mercer is the Network Manager for the Canadian Centre for Applied Research in Cancer Control (ARCC). Rebecca works as a Research Lead with Ontario Health, under the Provincial Drug Reimbursement Programs. She has significant experience with knowledge translation, and an interest in facilitating information transfer among stakeholders. Rebecca received her PhD in Medical Genetics from the University of Alberta in 2012, and also holds an Honours BSc in Biomedical Sciences from the University of Guelph.
Dr. Stuart Peacock, D. Phil - (ARCC Co-Director)
Stuart Peacock is Professor and Leslie Diamond Chair in Cancer Survivorship in the Faculty of Health Sciences at Simon Fraser University. He is Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC), Head of the Department of Cancer Control Research at BC Cancer, and a Fellow of the Canadian Academy of Health Sciences. Stuart has 25 years of experience in health economics, quality of life research, public and patient engagement, and priority setting in health and public policy. His interests include developing more effective cancer services, making health system funding decisions fairer and more transparent, and improving the quality of life of cancer patients and survivors. Stuart has acted as a consultant on priority-setting methods for the WHO, and for governments in the Americas, Asia, Australia and Europe.
Ms. Kim van der Hoek (ARCC Centre Manager)
Kim van der Hoek is the Centre Manager for the Canadian Centre for Applied Research in Cancer Control. Her previous research experience includes managing the Centre for Health Economics in Cancer at the BC Cancer Agency (BCCA), working on projects pertaining to cost-effective of chemotherapy drugs, quality of life in people with cancer and the economic evaluation of screening and diagnostic technologies. Prior to her BCCA role she was a project coordinator with the Alberta Cancer Board. She received her undergraduate and Master’s degree in Kinesiology from the Simon Fraser University in British Columbia. In a previous life Kim was heptathlete and competed for Canada internationally.